Advanced search
Publication Cover
Blood Pressure Volume 27, 2018 - Issue 3
Submit an article Journal homepage
2,628
Views
4
CrossRef citations to date
0
Altmetric
Original Article

A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension

Hiromi RakugiDepartment of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; View further author information
,
Kohei ShimizuTakeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, JapanView further author information
,
Yuya NishiyamaTakeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, JapanCorrespondence[email protected]
View further author information
,
Yuhei SanoTakeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, JapanView further author information
&
Yuusuke UmedaTakeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, JapanView further author information
Pages 125-133 | Received 08 Aug 2017, Accepted 30 Nov 2017, Published online: 13 Dec 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.